{"id":"W4411300972","doi":"10.1158/2159-8290.cd-24-1500","title":"Phase Ib Basket Expansion Trial and Alternative-Schedule Dose-Escalation Study of ATR Inhibitor Elimusertib in Advanced Solid Tumors with DNA Damage Response Defects","year":2025,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institutes of Health; Bayer; U.S. Department of Defense","keywords":"DNA damage; DNA; Schedule; Phase (matter); Maximum tolerated dose; Cancer research; Computational biology; Medicine; Biology; Chemistry; Clinical trial; Genetics; Internal medicine; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002301863,0.001546294,0.002265384,0.0006514572,0.0003385967,0.001173634,0.001114655,0.00108537,0.003576696],"category_scores_gemma":[0.0008733065,0.0005506982,0.00105264,0.0007763925,0.0007474636,0.001420682,0.0006153522,0.002689897,0.0008759032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001165124,"about_ca_system_score_gemma":0.00117528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008261643,"about_ca_topic_score_gemma":0.002010684,"domain_scores_codex":[0.9993787,0.0002725449,0.00004331052,0.00009493289,0.00008395914,0.000126409],"domain_scores_gemma":[0.9993322,0.00007786087,0.0001881964,0.00006913185,0.0000508611,0.0002816288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6803401,0.04923671,0.01260155,0.0007426985,0.001222003,0.0005717261,0.0003539972,0.004558161,0.07114393,0.0007832095,0.009925039,0.1685209],"study_design_scores_gemma":[0.6680947,0.3043379,0.01386467,0.00003501311,0.0004102567,0.0008175223,0.00005705389,0.002768885,0.005580369,0.0005098835,0.003461538,0.00006208966],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940459,0.001246583,0.0005110737,0.0003707825,0.00006917224,0.00143463,0.0008612734,0.0000867606,0.001373762],"genre_scores_gemma":[0.9843014,0.001431739,0.00410245,0.001086426,0.0002349136,0.002808488,0.003582984,0.00005597158,0.002395658],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003576696,"threshold_uncertainty_score":0.01217353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009876035978115252,"score_gpt":0.3082849068221279,"score_spread":0.2984088708440126,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}